Class information for:
Level 1: PENTOXIFYLLINE//LISOFYLLINE//HEMORRHEOLOGIC AGENTS

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
8882 1208 30.8 66%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
8 4 CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL 1276458
213 3       BURNS//CRITICAL CARE MEDICINE//SEPSIS 51408
3412 2             PENTOXIFYLLINE//PROPENTOFYLLINE//BUFLOMEDIL 1593
8882 1                   PENTOXIFYLLINE//LISOFYLLINE//HEMORRHEOLOGIC AGENTS 1208

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 PENTOXIFYLLINE authKW 2848361 30% 31% 367
2 LISOFYLLINE authKW 203097 1% 54% 15
3 HEMORRHEOLOGIC AGENTS authKW 56870 0% 75% 3
4 GUDE address 53839 1% 30% 7
5 CTP 499 authKW 50552 0% 100% 2
6 METABOLITE 1 authKW 50552 0% 100% 2
7 METHYLXANTHINE DERIVATIVES authKW 50552 0% 100% 2
8 MOLSIDOMIN authKW 50552 0% 100% 2
9 PENTOXIPHYLLINE authKW 48602 0% 38% 5
10 GEN VASC SURG TRANSPLANTOL address 45494 0% 60% 3

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Pharmacology & Pharmacy 1270 21% 0% 251
2 Critical Care Medicine 840 5% 0% 66
3 Peripheral Vascular Diseases 779 8% 0% 98
4 Immunology 576 12% 0% 146
5 Medicine, Research & Experimental 528 9% 0% 107
6 Hematology 385 6% 0% 75
7 Transplantation 328 4% 0% 46
8 Surgery 317 11% 0% 130
9 Urology & Nephrology 245 5% 0% 59
10 Medicine, General & Internal 152 7% 0% 83

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 GUDE 53839 1% 30% 7
2 GEN VASC SURG TRANSPLANTOL 45494 0% 60% 3
3 ABT NICHT INVAS DIAGNOST 25276 0% 100% 1
4 ANIM SCI MOLEC IMMUNOL 25276 0% 100% 1
5 BIOPHYSIOL PHARMACOL 25276 0% 100% 1
6 CARDIOVASC THORAX SURG 25276 0% 100% 1
7 ENDOCRINOL METABSACRED HEART HOSP 25276 0% 100% 1
8 ERASMUS HOSP NEPHROL 25276 0% 100% 1
9 EXPT NEUROBIOL NEUROIMAGERY 25276 0% 100% 1
10 GEENDIAB SPANISH GRP STUDY DIABET NEPHROPATHY 25276 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 RICERCA IN CLINICA E IN LABORATORIO 39739 2% 6% 28
2 PHARMATHERAPEUTICA 15701 1% 4% 14
3 JOURNAL OF MEDICINE 13445 1% 3% 17
4 CLINICAL HEMORHEOLOGY 11619 2% 2% 21
5 ANGIOLOGY 9237 3% 1% 41
6 CIRCULATORY SHOCK 4178 1% 1% 14
7 JOURNAL OF CARDIOVASCULAR MEDICINE-US 2807 0% 11% 1
8 IMMUNOPHARMACOLOGY 2281 1% 1% 11
9 CRITICAL CARE MEDICINE 1654 2% 0% 28
10 RENAL FAILURE 1360 1% 0% 14

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 PENTOXIFYLLINE 2848361 30% 31% 367 Search PENTOXIFYLLINE Search PENTOXIFYLLINE
2 LISOFYLLINE 203097 1% 54% 15 Search LISOFYLLINE Search LISOFYLLINE
3 HEMORRHEOLOGIC AGENTS 56870 0% 75% 3 Search HEMORRHEOLOGIC+AGENTS Search HEMORRHEOLOGIC+AGENTS
4 CTP 499 50552 0% 100% 2 Search CTP+499 Search CTP+499
5 METABOLITE 1 50552 0% 100% 2 Search METABOLITE+1 Search METABOLITE+1
6 METHYLXANTHINE DERIVATIVES 50552 0% 100% 2 Search METHYLXANTHINE+DERIVATIVES Search METHYLXANTHINE+DERIVATIVES
7 MOLSIDOMIN 50552 0% 100% 2 Search MOLSIDOMIN Search MOLSIDOMIN
8 PENTOXIPHYLLINE 48602 0% 38% 5 Search PENTOXIPHYLLINE Search PENTOXIPHYLLINE
9 PENTOXIFYLLINE THERAPEUTIC USE 45494 0% 60% 3 Search PENTOXIFYLLINE+THERAPEUTIC+USE Search PENTOXIFYLLINE+THERAPEUTIC+USE
10 PENTOXIFYLLINE PTX 33700 0% 67% 2 Search PENTOXIFYLLINE+PTX Search PENTOXIFYLLINE+PTX

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 WARD, A , CLISSOLD, SP , (1987) PENTOXIFYLLINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND ITS THERAPEUTIC EFFICACY.DRUGS. VOL. 34. ISSUE 1. P. 50-97 95 75% 624
2 SCHEFFLER, A , DRIESSEN, G , (1998) EXPERIMENTAL EFFECTS OF VASOACTIVE DRUGS FROM THE PHYSIOPATHOLOGICAL POINT OF VIEW.VASA-JOURNAL OF VASCULAR DISEASES. VOL. . ISSUE . P. 43 -60 127 50% 0
3 LEPORINI, C , PISANO, A , RUSSO, E , D'ARRIGO, G , DE SARRO, G , COPPOLINO, G , BOLIGNANO, D , (2016) EFFECT OF PENTOXIFYLLINE ON RENAL OUTCOMES IN CHRONIC KIDNEY DISEASE PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS.PHARMACOLOGICAL RESEARCH. VOL. 107. ISSUE . P. 315 -332 30 81% 1
4 SAMLASKA, CP , WINFIELD, EA , (1994) PENTOXIFYLLINE.JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. VOL. 30. ISSUE 4. P. 603-621 72 55% 175
5 GROESDONK, HV , HERINGLAKE, M , HEINZE, H , (2009) ANTI-INFLAMMATORY EFFECTS OF PENTOXIFYLLINE IMPORTANCE IN CARDIAC SURGERY.ANAESTHESIST. VOL. 58. ISSUE 11. P. 1136 -+ 36 63% 1
6 BADRI, S , DASHTI-KHAVIDAKI, S , LESSAN-PEZESHKI, M , ABDOLLAHI, M , (2011) A REVIEW OF THE POTENTIAL BENEFITS OF PENTOXIFYLLINE IN DIABETIC AND NON-DIABETIC PROTEINURIA.JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES. VOL. 14. ISSUE 1. P. 128-137 31 66% 12
7 FRAMPTON, JE , BROGDEN, RN , (1995) PENTOXIFYLLINE (OXPENTIFYLLINE) - A REVIEW OF ITS THERAPEUTIC EFFICACY IN THE MANAGEMENT OF PERIPHERAL VASCULAR AND CEREBROVASCULAR DISORDERS.DRUGS & AGING. VOL. 7. ISSUE 6. P. 480-503 53 58% 56
8 NASIRI-TOOSI, Z , DASHTI-KHAVIDAKI, S , KHALILI, H , LESSAN-PEZESHKI, M , (2013) A REVIEW OF THE POTENTIAL PROTECTIVE EFFECTS OF PENTOXIFYLLINE AGAINST DRUG-INDUCED NEPHROTOXICITY.EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 69. ISSUE 5. P. 1057-1073 34 52% 12
9 WINDMEIER, C , GRESSNER, AM , (1997) PHARMACOLOGICAL ASPECTS OF PENTOXIFYLLINE WITH EMPHASIS ON ITS INHIBITORY ACTIONS ON HEPATIC FIBROGENESIS.GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM. VOL. 29. ISSUE 2. P. 181-196 61 41% 79
10 PARKER, SJ , BROWN, D , KENWARD, CE , WATKINS, PE , (2000) PENTOXIFYLLINE FAILS TO IMPROVE ORGAN DYSFUNCTION AND SURVIVAL WHEN USED IN THE RESUSCITATION OF A PORCINE MODEL OF HAEMORRHAGE AND ABDOMINAL SEPSIS.RESUSCITATION. VOL. 44. ISSUE 1. P. 61 -69 30 83% 5

Classes with closest relation at Level 1


Rank Class id link
1 29608 BUFLOMEDIL//PYRROLIDINES THERAPEUTIC USE//CAS 55837 25 7
2 31754 PROPENTOFYLLINE//HYDROXYPROPENTOFYLLINE//MEDULLARY VISCERAL ZONE
3 34429 ACID ASPIRATION//GASTRIC ASPIRATION PNEUMONIA//PARTICULATE ASPIRATION
4 33214 MOL PHYSIOL GENET//L1210 CELL LINE//APOPTOSIS EFFECTOR GENES
5 20077 DIABETIC NEPHROPATHY//URINE CYTOKINES CHEMOKINES//TNF SYSTEM
6 1445 CLINICAL HEMORHEOLOGY//CLINICAL HEMORHEOLOGY AND MICROCIRCULATION//ERYTHROCYTE DEFORMABILITY
7 16864 G2 REPAIR//G2 DELAY//G2 M BLOCK ABROGATION
8 29321 INTERFERON INHIBITORS//ALPHA BETA TYPE 1 INTERFERON RECEPTORS//BUFFALO GEN HOSP INTERNAL MED
9 16511 HEMODILUTION//CLINICAL HEMORHEOLOGY//CLIN HAEMOSTASIOL TRANSFUS MED
10 37587 IBUDILAST//CAS 50847 11 5//3 ISOBUTYRYL 2 ISOPROPYLPYRAZOLO1 5 APYRIDINE PHARMACOLOGY

Go to start page